Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1644 1646
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18465854 | COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17754992 | METHODS TO PREPARE V-T CELLS DERIVED EXOSOMES FOR TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED CANCERS | Final Rejection | THE UNIVERSITY OF HONG KONG |
| 18025879 | METHODS, THERAPIES AND USES FOR TREATING CANCER | Non-Final OA | PFIZER INC. |
| 17240609 | Materials and Methods for Treating Juvenile Idiopathic Arthritis | Final Rejection | Janssen Biotech, Inc. |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | Non-Final OA | University of Miami |
| 17312855 | Models and Methods Useful for the Treatment of Serrated Colorectal Cancer | Non-Final OA | Sanford Burnham Prebys Medical Discovery Institute |
| 17286247 | METHOD FOR THE TREATMENT OF MYASTHENIA GRAVIS | Final Rejection | UCB BIOPHARMA SRL |
| 18260905 | ROR1-TARGETING ANTIBODY AND USE THEREOF | Non-Final OA | BIOHENG THERAPEUTICS LIMITED |
| 18361775 | PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY | Final Rejection | Aurinia Pharmaceuticals Inc. |
| 18324105 | GENETICALLY ENGINEERED DENDRITIC CELLS TO ACTIVATE PROTEIN SPECIFIC T CELLS FOR THE TREATMENT OF VIRAL AND OTHER PATHOGENIC INFECTIONS | Non-Final OA | NeyroblastGX LLC, |
| 16586730 | METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (aCAR)/INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR) PAIRS FOR USE IN CANCER THERAPIES | Non-Final OA | GAVISH-GALILEE BIO APPLICATIONS LTD. |
| 18003076 | ANTI-CTLA-4 BINDING PROTEINS AND METHODS OF USE THEREOF | Final Rejection | GigaGen, Inc. |
| 17616575 | BISPECIFIC BINDING CONSTRUCTS WITH SELECTIVELY CLEAVABLE LINKERS | Final Rejection | AMGEN RESEARCH (MUNICH) GMBH |
| 17368815 | USE OF AN ANTI-CD45 ANTIBODY DRUG CONJUGATE (ADC) IN CELL THERAPY | Final Rejection | Magenta Therapeutics, Inc. |
| 17050988 | COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES | Final Rejection | ILC Therapeutics LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy